Oncology News: Symptom Burden Linked to Less Spending on Cancer Treatment (+...)

Oncology News Symptom Burden Linked to Less Spending on Cancer Treatment A higher patient-reported symptom burden is linked to less spending on cancer treatment but more spending on emergency visits, hospital stays, and home care, a study finds. Medscape Medical News, November 10, 2026 https://www.medscape.com/index/list_13474_0

Symptom Burden Linked to Less Spending on Cancer Treatment Will Pass

https://www.medscape.com/viewarticle/symptom-burden-linked-less-spending-cancer-treatment-2026a10016wm?src= In people with cancer, a higher patient-reported symptom burden was linked to lower spending on cancer treatment and higher spending on other care. Among nearly 286,000 patients in their first year after diagnosis, each 10-point increase in symptom score was associated with a 9.4% decrease in cancer-directed costs over the next 30 days, in the large population-based study from Ontario, Canada. Each 10-point increase was also associated with 18.4% higher ancillary costs, such as emergency department visits, hospital stays, and home care, whereas total costs were 4.1% lower.

Lung Cancer Screening Lags Amid Low Awareness and Health Access Tara Haelle

https://www.medscape.com/viewarticle/lung-cancer-screening-lags-amid-low-awareness-and-health-2026a10016o5?ecd=WNL_trdalrt_pos1_ous_261110_etid8886262&uac=148436CN&impID=8886262 PHOENIX — Lung cancer screenings have continued to lag behind other types of cancer screenings, due in part to a communication gap in which few people eligible for screening are discussing their risk with clinicians, according to findings presented at CHEST, the annual meeting of the American College of Chest Physicians, in Phoenix on October 20.

Why the latest heart drug failures should make us all more skeptical of AI hype A pioneering new approach was supposed to transform biopharma research. Instead, it flopped

https://www.statnews.com/2026/11/08/heart-drug-failures-lessons-for-artificial-intelligence-from-aha-conference/ By Matthew HerperNov. 8, 2026 Senior Writer, Medicine, Editorial Director of Events Matthew Herper matthew.herper@statnews.com Matthew Herper covers medical innovation — both its promise and its perils.

Liver experts finally agree on what acute-on-chronic liver failure is In Q&A, an architect of the new criteria expresses hope it will expedite treatment By Isabella CuetoNov. 9, 2026 Chronic Disease Reporter

https://www.statnews.com/2026/11/09/acute-on-chronic-liver-failure-new-definition/

AI chatbots aren’t therapists. But can they finally get men to open up? Men often say they feel more comfortable and less judged when conversing with a bot By Annalisa MerelliNov. 9, 2026 Contributing Writer

https://www.statnews.com/2026/11/09/ai-chatbots-can-overcome-mental-health-barriers-in-men/

Ch 1: Overview of C3G and Diagnosis Challenges

Bradley Dixon, MD, a pediatric nephrologist, and Chief of Pediatric Nephrology, Children’s Hospital of Colorado, and Professor of Pediatrics, University of Colorado School of Medicine, discusses complement 3 glomerulopathy (C3G) and its diagnostic challenges.